Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection

Quraishi, M. N., Widlak, M., Bhala, N., Moore, D., Price, M., Sharma, N., Iqbal, T. H.·2017·Alimentary Pharmacology & Therapeutics
DOI 10.1111/apt.14201

Cited by (618)

Items 201–300 of 618

  1. Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives
    Ivana Cibulková, Veronika Řehořová, Jan Hajer, František Duška · 2021 · Biomolecules
  2. Role of the Gut–Liver Axis in Driving Parenteral Nutrition-Associated Injury
    Christine Denton, Amber Price, Julie Friend, Chandrashekhara Manithody, Keith Blomenkamp, Matthew Westrich, Vindhya Kakarla, William Phillips, Joseph Krebs, Armando Salim Munoz‐Abraham et al. · 2018 · Children
  3. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement
    Massimo M. Antonelli, Ignacio Martín‐Loeches, George Dimοpoulos, Antonio Gasbarrini, Maria Sole Vallecoccia · 2020 · Intensive Care Medicine
  4. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study
    Sabrina Just Kousgaard, Thomas Yssing Michaelsen, Hans Linde Nielsen, Karina Frahm Kirk, Jakob Brandt, Mads Albertsen, Ole Thorlacius‐Ussing · 2020 · Scandinavian Journal of Gastroenterology
  5. Microbiome-Based Interventions for Food Safety and Environmental Health
    Blessing Oteta Simon, Nnabueze Darlington Nnaji, Christian Kosisochukwu Anumudu, Job Chinagorom Aleke, Chiemerie Theresa Ekwueme, Chijioke Christopher Uhegwu, Francis Chukwuebuka Ihenetu, Promiselynda Obioha, Onyinye Victoria Ifedinezi, Precious Somtochukwu Ezechukwu et al. · 2025 · Applied Sciences
  6. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential
    Christopher Bulow, Amy Elizabeth Langdon, Tiffany Hink, Meghan A. Wallace, Kimberly A. Reske, Sanket Patel, Xiaoqing Sun, Sondra M. Seiler, Susan Jones, Jennie H. Kwon et al. · 2018 · mSphere
  7. Where Stool is a Drug: International Approaches to Regulating the use of Fecal Microbiota for Transplantation
    Alexandra Scheeler · 2019 · The Journal of Law Medicine & Ethics
  8. The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
    Simon D. Goldenberg, Blair Merrick · 2021 · Therapeutic Advances in Infectious Disease
  9. Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?
    Daniel Popa, Bogdan Mihai Neamtu, Manuela Mihalache, Adrian Boicean, Adela Banciu, Daniel Dumitru Banciu, Doru Florian Cornel Moga, Victoria Bîrluțiu · 2021 · Journal of Clinical Medicine
  10. Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial
    Jessica S.W. Borgers, Femke H. Burgers, Elisabeth M. Terveer, Monique Esther van Leerdam, Catharina M. Korse, Rob Kessels, Claudie C. Flohil, Christian U. Blank, Ton N. Schumacher, M. van Dijk et al. · 2022 · BMC Cancer
  11. Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients
    Katie Rose Conover, Imad Absah, Sonia Arora Ballal, David E. Brumbaugh, Stanley Cho, Maria Camila Cardenas, Elizabeth Doby Knackstedt, Alka Goyal, M. Kyle Jensen, Jess L. Kaplan et al. · 2023 · Journal of Pediatric Gastroenterology and Nutrition
  12. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spaish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR)
    Instituto de Investigación Sanitaria Gregorio Marañón Servicio de Microbiología Clínica y E. Infecciosas, Emilio Bouza, José María Aguado, Luís Alcalá, Benito Almirante, Patricia Alonso‐Fernández, Marcío Borges-Sa, Javier Cobo, Jordi Guardiola, Juan Pablo Horcajada et al. · 2020 · Revista Española de Quimioterapia
  13. Preoperative bowel stimulation prior to ileostomy closure to restore bowel function more quickly and improve postoperative outcomes: a systematic review
    Tanja Rombey, Ioanna Panagiotopoulou, Daniel Hind, Nicola S. Fearnhead · 2019 · Colorectal Disease
  14. Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review
    Frederik Cold, Sabrina Just Kousgaard, Sofie Ingdam Halkjær, Andreas Munk Petersen, Hans Linde Nielsen, Ole Thorlacius‐Ussing, Lars Hestbjerg Hansen · 2020 · Microorganisms
  15. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile
    Emily N. Tixier, Elijah Verheyen, Yuying Luo, Lauren Tal Grinspan, Charles Du, Ryan C. Ungaro, Samantha Walsh, Ari M. Grinspan · 2021 · Digestive Diseases and Sciences
  16. Current clinical translation of microbiome medicines
    Laura E. McCoubrey, Moe Elbadawi, Abdul W. Basit · 2022 · Trends in Pharmacological Sciences
  17. The practice of fecal microbiota transplantation in inflammatory bowel disease
    Umang Arora, Saurabh Kedia, Vineet Ahuja · 2023 · Intestinal Research
  18. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond
    Vinod Kumar, Monika Fischer · 2019 · Expert Opinion on Biological Therapy
  19. Fecal Microbiota Transfer
    Andreas Stallmach, Arndt Steube, Philip Grunert, Michael Hartmann, Lena M. Biehl, Maria J. G. T. Vehreschild · 2020 · Deutsches Ärzteblatt international
  20. Assessment of Gram- and Viability-Staining Methods for Quantifying Bacterial Community Dynamics Using Flow Cytometry
    Aurore Duquenoy, Samuel Bellais, Cyrielle Gasc, Carole Schwintner, Joel M. Dore, Vincent Thomas · 2020 · Frontiers in Microbiology
  21. Fecal microbiota transplantation in recurrent <i>Clostridium difficile</i> infection: A retrospective single‐center chart review
    Kim, Pamela, Gadani, Akash, Abdul‐Baki, Heitham, Mitre, Ricardo, Mitre, Marcia · 2019 · JGH Open
  22. Fecal microbiota transplantation accelerates restoration of florfenicol-disturbed intestinal microbiota in a fish model
    Zhuo-Ran Han, Jing-Feng Sun, Boyun Jiang, Kun Chen, Lunhua Ge, Zhongshi Sun, Anli Wang · 2024 · Communications Biology
  23. Management of Clostridioides difficile colitis: insights for the gastroenterologist
    Srishti Saha, Sahil Khanna · 2019 · Therapeutic Advances in Gastroenterology
  24. Tutorial on Diarrhea and Enteral Nutrition: A Comprehensive Step‐By‐Step Approach
    Marina Regueira Pitta, Franciele Maciel Campos, Alline Gonçalves Monteiro, A.G.F. Cunha, Juliana Dourado Porto, Raquel Rodrigues Gomes · 2019 · Journal of Parenteral and Enteral Nutrition
  25. Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
    Hui-jun Zhao, Xiao‐Jing Zhang, Nana Zhang, Bin Yan, Keke Xu, Lihua Peng, Fei Pan · 2022 · Frontiers in Nutrition
  26. Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies
    Parul Berry, Sahil Khanna · 2023 · BioDrugs
  27. Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway
    Xin Ma, Meng Li, Yuanyuan Zhang, Tingting Xu, Xinchen Zhou, Mengqi Qian, Zhiren Yang, Xinyan Han · 2025 · eLife
  28. The frontier of health: Exploring therapeutic potentials of the microbiome
    Mohammad Abavisani, Sobhan Karbas Foroushan, Prashant Kesharwani, Amirhossein Sahebkar · 2025 · PharmaNutrition
  29. Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection
    Frederik Emil Juul, Michael Bretthauer, Peter Holger Johnsen, Faye Samy, Kristian Tonby, Jan‐Erik Berdal, Dag Arne Lihaug Hoff, Eirik Hugaas Ofstad, Awet Abraham, Birgitte Seip et al. · 2025 · Annals of Internal Medicine
  30. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection
    Srishti Saha, Kristin C. Mara, Darrell S. Pardi, Sahil Khanna · 2020 · Clinical Infectious Diseases
  31. Next Generation Fecal Microbiota Transplantation
    Tae‐Geun Gweon, Soo‐Young Na · 2021 · Clinical Endoscopy
  32. Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
    Paul Feuerstadt, Olga C. Aroniadis, Felicia L. Svedlund, Mariana B. Garcia, Laura Stong, Mena Boules, Sahil Khanna · 2021 · Digestive Diseases and Sciences
  33. Nanotechnological interventions of the microbiome as a next-generation antimicrobial therapy
    Rashmi Trivedi, Tarun Kumar Upadhyay, Mohd Adnan Kausar, Amir Saeed, Amit Baran Sharangi, Ahmad Almatroudi, Nadiyah M. Alabdallah, Mοhd Saeed, Farrukh Aqil · 2022 · The Science of The Total Environment
  34. Fecal microbiota transplantation: Current evidence and future directions
    Michael Cymbal, Arjun Chatterjee, Brian B. Baggott · 2025 · Cleveland Clinic Journal of Medicine
  35. Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection
    Zainab Abdali, Tracy Elizabeth Roberts, Pelham M Barton, Peter Michael Hawkey · 2020 · EClinicalMedicine
  36. Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus
    Xiaolan Zhou, Rumeng Chen, Yichen Cai, Qiu Chen · 2024 · Diabetes Metabolic Syndrome and Obesity
  37. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine?
    Martina Takáčová, Alojz Bomba, Csilla Tóthová, Alena Micháľová, Hana Turňa · 2022 · Life
  38. Five years of fecal microbiota transplantation - an update of the Israeli experience
    Sharon A. Greenberg, Ilan Youngster, Nathaniel A. Cohen, Dan Meir Livovsky, Jacob Strahilevitz, Eran Israeli, Ehud Melzer, Kalman Paz, Naomi Fliss Isakov, Nitsan Maharshak · 2018 · World Journal of Gastroenterology
  39. Critical illness and the role of the microbiome
    Shunsuke Otani, Deena B. Chihade, Craig M. Coopersmith · 2018 · Acute Medicine & Surgery
  40. Fecal microbiota transplantation in children: current concepts
    Bhaskar Gurram, Paul K. Sue · 2019 · Current Opinion in Pediatrics
  41. The gut microbiome: what every gastroenterologist needs to know
    Benjamin Harvey Mullish, Mohammed Nabil Quraishi, Jonathan Philip Segal, Gianluca Ianiro, Tariq H Iqbal · 2020 · Frontline Gastroenterology
  42. Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection
    Michael A. Henson · 2021 · PLoS Computational Biology
  43. Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy—A Narrative Review
    Marco Isidori, Ronald Jan Corbee, Massimo Trabalza‐Marinucci · 2022 · Veterinary Sciences
  44. Retrospective Analysis of the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTATM) Administered Under Enforcement Discretion to Patients With Clostridioides difficile Infection
    Paul Feuerstadt, Adam Harvey, David S. Yoho, Julia Garcia‐Diaz, W Knapple, Lindy L. Bancke · 2023 · Open Forum Infectious Diseases
  45. Impact of hyperoxia on the gut during critical illnesses
    Ninan Dai, Juan Gu, Yanhong Luo, Yuanfa Tao, Yueh-Ting Chou, Ying He, Han Qin, Tao Chen, Xiaoyun Fu, Miao Chen et al. · 2024 · Critical Care
  46. Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation
    Tien-Ching Lin, Yuan‐Pin Hung, Wen‐Chien Ko, Jhen‐Wei Ruan · 2019 · Journal of Microbiology Immunology and Infection
  47. Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances
    Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Cornelia Călina, Javad Sharifi‐Rad · 2024 · European journal of medical research
  48. Gut microbiota and tuberculosis infection: interaction and therapeutic potential
    Yinghui Chai, Min Li, Xianping Deng, Congcong Ma, Nannan Zhou, Yanan Chen, Yushan Yao, Kang Cong Li, Wenping Gong, Hong Lei · 2025 · Gut Microbes
  49. Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection
    Elida R. Voth, Sahil Khanna · 2020 · Expert Review of Anti-infective Therapy
  50. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
    Olle Björkqvist, Ignacio Rangel, Lena Serrander, Cecilia Magnusson, Jonas Halfvarson, Torbjörn Norén, Malin Bergman Jungeström · 2021 · PLoS ONE
  51. Update on gut microbiota in gastrointestinal diseases
    Atsushi Nishida, Kyohei Nishino, Masashi Ohno, Keitaro Sakai, Yuji Owaki, Yoshika Noda, Hirotsugu Imaeda · 2022 · World Journal of Clinical Cases
  52. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis
    Damjana Bogatic, Robert Venning Bryant, Kate Diana Lynch, Samuel Paul Costello · 2022 · Alimentary Pharmacology & Therapeutics
  53. Fresh Versus Frozen Versus Lyophilized Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
    Manesh Kumar Gangwani, Muhammad Aziz, Abeer Aziz, Fnu Priyanka, Simcha I Weissman, Khiem Phan, Dushyant Singh Dahiya, Zohaib Ahmed, Amir Humza Sohail, Wade Lee‐Smith et al. · 2022 · Journal of Clinical Gastroenterology
  54. Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection
    Paul Feuerstadt, Jessica Ravikoff Allegretti, Sahil Khanna · 2023 · The American Journal of Gastroenterology
  55. Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19
    Jilei Zhang, Yongguo Zhang, Yinglin Xia, Jun Sun · 2023 · Genes & Diseases
  56. Safety and feasibility of faecal microbiota transplantation for patients with Parkinson’s disease: a protocol for a self-controlled interventional donor-FMT pilot study
    Karuna E.W. Vendrik, Vlada O Chernova, Ed J. Kuijper, Elisabeth M. Terveer, Jacobus Johannes van Hilten, Maria Fiorella Contarino · 2023 · BMJ Open
  57. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases
    Ziying Han, Yiyang Min, Ke Pang, Dong Wu · 2023 · International Journal of Molecular Sciences
  58. The efficacy of fecal microbiota transplantation for patients with chronic pouchitis: A case series
    Atsushi Nishida, Hirotsugu Imaeda, Osamu Inatomi, Shigeki Bamba, Mitsushige Sugimoto, Akira Andoh · 2019 · Clinical Case Reports
  59. Comorbidity Development in Patients with Severe Brain Injury Resulting in Chronic Critical Condition (Review)
    A Parfenov, Marina V. Petrova, Ирина Михайловна Пичугина, E. V. Luginina · 2020 · General Reanimatology
  60. The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics
    Moshe Maor, Hilit Levy Barazany, Ilana Kolodkin‐Gal · 2025 · Gut Microbes
  61. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
    Xiaochen Zhang, Dai Ishikawa, Toshifumi� Ohkusa, Shinji Fukuda, Akihito Nagahara · 2022 · Frontiers in Medicine
  62. Fecal Microbiota Transplantation as a Cancer Therapeutic
    Ronen Stoff, Yochai Wolf, Ben Boursi · 2023 · The Cancer Journal
  63. The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation
    Salam P. Bachour, Rahul S. Dalal, Jessica Ravikoff Allegretti · 2023 · Therapeutic Advances in Gastroenterology
  64. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
    Sahil Khanna · 2021 · Journal of Internal Medicine
  65. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status
    Stephen D. H. Malnick, David L. Fisher, Marina Somin, Manuela G. Neuman · 2021 · Biology
  66. Emerging drugs for the treatment of clostridium difficile
    Giovanni Cammarota, Antonella Gallo, Gianluca Ianiro, Massimo Montalto · 2019 · Expert Opinion on Emerging Drugs
  67. Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials
    Abdullah A. Alhifany, Abdulaali R. Almutairi, Thamer A. Almangour, Alaa N. Shahbar, Ivo L Abraham, Mohammed Yousef Alessa, Faris S. Alnezary, Ejaz Ullah Cheema · 2019 · BMJ Open
  68. Fecal microbiota transplants: A review of emerging clinical data on applications, efficacy, and risks (2015–2020)
    Dana Al‐Ali, Aamena Ahmed, Ameena Shafiq, Clare McVeigh, Ali Châari, Dalia Zakaria, Ghizlane Bendriss · 2021 · Qatar medical journal
  69. Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study)
    Aurore Dougé, Aurélie Ravinet, Alexandrine Corriger, Aurélie Cabrespine, Mathieu Wasiak, Bruno Pereira, Harry Sokol, Stéphanie Nguyen, Jacques‐Olivier Bay · 2023 · BMJ Open
  70. Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
    Juan Zhang, Honggang Wang, Ying Liu, Min Shi, Minna Zhang, Hong Zhang, Juan Chen · 2024 · Frontiers in Cellular and Infection Microbiology
  71. Ethical implications of recruiting universal stool donors for faecal microbiota transplantation
    Moiz Mikail, Kieran C. O’Doherty, Susan Marie Poutanen, Susy S. Hota · 2019 · The Lancet Infectious Diseases
  72. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
    Hyuk Yoon, Hyun Ik Shim, Mijin Seol, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee · 2020 · Gut and Liver
  73. Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2
    Devvrat Yadav, Sahil Khanna · 2021 · Therapeutic Advances in Gastroenterology
  74. Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats
    Fangyuan Zhu, Yifan Ke, Yiting Luo, Jiaqian Wu, Pei Wu, Fangxiao Ma, Yingchao Liu · 2021 · Frontiers in Microbiology
  75. Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
    Mehmet Yalchin, Jonathan Philip Segal, Benjamin Harvey Mullish, Mohammed Nabil Quraishi, Tariq H Iqbal, Julian Roberto Marchesi, Ailsa L Hart · 2019 · Therapeutic Advances in Gastroenterology
  76. Signaling pathways and targeted interventions for precancers
    Jierui Yang, Shimeng Wang, Xin Li, H. Eric Xu, Tongxu Sun, Tao Hu, Jingjing Luo, H. Zhou · 2026 · Signal Transduction and Targeted Therapy
  77. The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review
    Abhay Thandavaram, Aneeta Channar, Ansh Purohit, Bijay Shrestha, Deepkumar Patel, Hriday Shah, Kerollos S Hanna, Harkirat Kaur, Mohammad S Alazzeh, Lubna Mohammed · 2022 · Cureus
  78. Potential Effects of Regulating Intestinal Flora on Immunotherapy for Liver Cancer
    Xiang-Dong Yan, Liuhui Bai, Ping Qi, Jin Lv, Xiaojing Song, Lei Zhang · 2023 · International Journal of Molecular Sciences
  79. Targeting microbiota to alleviate the harm caused by sleep deprivation
    Hongyu Chen, Chen Wang, Junying Bai, Jiajia Song, Linli Bu, Liang Ming, Huayi Suo · 2023 · Microbiological Research
  80. Intestinal microbiota: a new perspective on delaying aging?
    Yuemeng Zhang, Xiaomei Wang, Wujuan Li, Yi Yang, Zhuoxuan Wu, Yuhong Lyu, Changwu Yue · 2023 · Frontiers in Microbiology
  81. Microbes as medicine
    Brendan A. Daisley, Emma Allen‐Vercoe · 2024 · Annals of the New York Academy of Sciences
  82. Faecal Transplant in GIT Treatment (Pilot Clinical Experience)
    Peter Scherbakov, N.D. Belova, Edward V. Generozov, Elena S. Zhgun, O.I. Ivanova, Elena Nikolaevna Ilina, Т. Н. Калачнюк, Alexander Vladimirovich Pavlenko, V.V. Podgorskiy, Alexander I. Manolov et al. · 2019 · Doctor Ru
  83. Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study
    Philipp Solbach, Patrick Chhatwal, Sabrina Woltemate, Evelina Tacconelli, Michael E. J. Buhl, Ingo B. Autenrieth, Maria J. G. T. Vehreschild, Nathalie Jazmati, Markus Gerhard, Christoph K. Stein‐Thoeringer et al. · 2020 · Clinical Infectious Diseases
  84. Emerging drugs for the treatment of primary sclerosing cholangitis
    Nadir Abbas, Mohammed Nabil Quraishi, Palak Jitendrakumar Trivedi · 2021 · Current Opinion in Pharmacology
  85. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence
    Yuying Luo, Emily N. Tixier, Ari M. Grinspan · 2020 · Digestive Diseases and Sciences
  86. Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway
    Xin Ma, Meng Li, Yuanyuan Zhang, Tingting Xu, Xinchen Zhou, Mengqi Qian, Zhiren Yang, Xinyan Han · 2023 · eLife
  87. Microbiome-Targeted Therapies in Gastrointestinal Diseases: Clinical Evidence and Emerging Innovations
    Enoch Chi Ngai Lim, Chi Eung Danforn Lim · 2025 · Acta Microbiologica Hellenica
  88. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases
    Paulina Núñez F, Rodrigo Quera, Constanza Bay M, Pamela Thomson M · 2021 · Gastroenterología y Hepatología
  89. Changes of intestinal microbiota and microbiota-based treatments in IBD
    Qianyu Li, Siyu Zhou, Yanna Wang, Jing Cong · 2022 · Archives of Microbiology
  90. The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study
    Camilla Kara Svensson, Frederik Cold, Iben Ribberholt, Mike Zangenberg, Hengameh Chloé Mirsepasi‐Lauridsen, Andreas Munk Petersen, Morten Helms · 2022 · Cells
  91. Effects of intestinal microbes on rheumatic diseases: A bibliometric analysis
    Runzhi Huang, Mengyi Zhang, Yuwei Lu, Dayuan Xu, Yifan Liu, Minghao Jin, Shuyuan Xian, Siqiao Wang, Xirui Tong, Jianyu Lu et al. · 2023 · Frontiers in Microbiology
  92. Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention
    Thomas Lavoie, Haley J. Appaneal, Kerry L. LaPlante · 2023 · Clinical Infectious Diseases
  93. Faecal microbiota transplantation in children : A systematic review
    Ella Lauwers, João Sabino, Ilse E. A. Hoffman, Karen van Hoeve · 2024 · Acta Paediatrica
  94. Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update
    Lindsay M. Clarke, Jessica Ravikoff Allegretti · 2024 · Alimentary Pharmacology & Therapeutics
  95. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients
    Hamzah Abu‐Sbeih, Kati Choi, Cynthia Nguyen Tran, Xuemei Wang, Phillip J. Lum, Gladis A. Shuttlesworth, John R. Stroehlein, Pablo C. Okhuysen, Yinghong Wang · 2018 · European Journal of Gastroenterology & Hepatology
  96. Faecal microbiota transfer in patients with microscopic colitis – a pilot study in collagenous colitis
    Savanne Holster, Julia Rode, Johan Bohr, Ashok Kumar Kumawat, Gábor Veress, Elisabeth Hultgren Hörnquist, Robert J. Brummer, Julia König · 2020 · Scandinavian Journal of Gastroenterology
  97. Different Substrate Preferences Help Closely Related Bacteria To Coexist in the Gut
    Petra Louis · 2017 · mBio
  98. Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection
    Fedja Farowski, Philipp Solbach, Anastasia Tsakmaklis, Susanne Brodesser, Marta Rebeca Cruz Aguilar, Oliver A. Cornely, Katja Dettmer, Paul G. Higgins, Sebastian Suerbaum, Nathalie Jazmati et al. · 2019 · Digestive and Liver Disease
  99. Fecal calprotectin and fecal indole predict outcome of fecal microbiota transplantation in subjects with recurrent Clostridium difficile infection
    J. Hibbard, Zhi‐Dong Jiang, Herbert L. DuPont · 2019 · Anaerobe
  100. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
    Danielle Barrios Steed, Tiffany L. Wang, Divyanshu Raheja, Alex D. Waldman, Ahmed Babiker, Tanvi Dhere, Colleen S. Kraft, Michael H. Woodworth · 2020 · mSphere